An announcement from medmix AG ( (CH:MEDX) ) is now available.
At the annual general meeting of medmix Ltd., shareholders approved all proposals from the Board of Directors, including the financial statements and a CHF 0.50 per share dividend. Key re-elections included Rob ten Hoedt as Chairman, and KPMG as auditor. These approvals reflect strong shareholder support and are expected to reinforce medmix’s strategic direction and operational stability.
More about medmix AG
medmix is a global leader in high-precision delivery devices, known for its innovation and technological advancement with over 900 active patents. The company operates 14 production sites worldwide and employs nearly 2,700 people, focusing on delivering quality and agility to its customers. Headquartered in Baar, Switzerland, medmix’s shares are traded on the SIX Swiss Exchange.
YTD Price Performance: 13.41%
Average Trading Volume: 61,511
Current Market Cap: CHF411.8M
For detailed information about MEDX stock, go to TipRanks’ Stock Analysis page.